Mithril Capital Management
Mithril is a global technology investment firm investing in the technology, macroeconomics and finance sectors.
Business Model: B2B
Revenue: $1.7M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Mithril Capital Management Information
Geographic Data
Address: 600 Congress Ave.
City: Austin
State: TX
Zip: 78701
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Facebook
Linkedin
Crunchbase
Metrics
5,229,119Website Global Rank
1,751Website Monthly Traffic
Twitter Followers
Description
Mithril is a family of long-term venture capital funds agnostic to sector and geography. They provide capital to leading growth companies by partnering with teams who use technology to build transformative and durable businesses.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2014 | Palantir Technologies | Series I | 444.2M |
| 2/2018 | C2FO | Series F | 100M |
| 12/2020 | Glance | Venture Round | 145M |
| 8/2015 | C2FO | Series E | 0 |
| 4/2014 | SilverRail Technologies | Series C | 40M |
| 5/2016 | Stem | Series C | 15M |
| 12/2020 | Paxos | Series C | 0 |
| 8/2014 | Helion Energy | Seed Round | 1.5M |
| 9/2014 | Fractyl Health | Series B | 19.8M |
| 8/2014 | MagForce | Post-IPO Equity | 15M |
| 10/2020 | Neocis | Series D | 72M |
| 10/2022 | Neocis | Series D | 0 |
| 9/2014 | Partnerize | Series B | 10M |
| 6/2015 | Classy | Series B | 0 |
| 6/2016 | Spaceflight Industries | Series B | 25M |
| 7/2013 | C2FO | Series C | 0 |
| 1/2016 | Helion Energy | Series B | 21.3M |
| 6/2017 | Avitide | Equity | 12M |
| 10/2022 | Genetesis | Series C | 0 |
| 9/2020 | Nuvia | Series B | 240M |
| 11/2021 | Helion Energy | Series E | 0 |
| 8/2014 | DoubleDutch | Series D | 15M |
| 11/2020 | Adagio Therapeutics | Series B | 0 |
| 8/2014 | Lookout | Series F | 150M |
| 10/2015 | AppDirect | Series E | 0 |
| 7/2020 | Adagio Therapeutics | Series A | 0 |
| 11/2016 | Classy | Series C | 0 |
| 4/2021 | Paxos | Series D | 0 |
| 10/2022 | Juno | Series A | 0 |
| 11/2021 | Ankyra | Series B | 45M |
| 4/2021 | Adagio Therapeutics | Series C | 0 |
| 9/2018 | GreyOrange | Series C | 140M |
| 5/2018 | Figure | Series A | 50M |
| 6/2018 | Capture2 | Series A | 4M |
| 5/2022 | GreyOrange | Venture Round | 0 |
| 3/2022 | AiFi | Series B | 0 |
| 4/2018 | Ment.io | Venture Round | 6M |
| 8/2020 | Fractyl Health | Series E | 0 |
| 2/2015 | AppDirect | Series D | 50M |
| 11/2017 | Fractyl Health | Series D | 0 |
| 9/2019 | Glance | Venture Round | 45M |
| 5/2022 | GreyOrange | Debt Financing | - |
| 3/2021 | ForSight Robotics | Seed Round | 10M |
| 6/2022 | Oma Fertility | Venture Round | 0 |
| 9/2016 | Avitide | Series D | - |
| 8/2022 | Fractyl Health | Series F | - |
| 10/2013 | Lookout | Series E | 55M |
| 6/2016 | Partnerize | Series C | 15.4M |
| 3/2021 | Flex Logix Technologies | Series D | 55M |
| 7/2022 | ForSight Robotics | Series A | 0 |
| 8/2017 | Auris Health | Series D | 0 |
| 11/2018 | Auris Health | Series E | 0 |
| 9/2020 | Treasure Financial | Seed Round | 0 |
| 6/2021 | Generation Home | Series A | 0 |
| 9/2021 | BlackSky Global | Post-IPO Equity | 180M |
| 3/2014 | Auris Health | Series A | 34.4M |
| 9/2015 | Auris Health | Series B | 149.5M |
| 11/2015 | Fractyl Health | Series C | 57M |
| 7/2019 | Neocis | Venture Round | 30M |
| 4/2014 | AppDirect | Series C | 35M |
| 7/2022 | ForSight Robotics | Series A | 0 |
| 6/2022 | Oma Fertility | Venture Round | 0 |
| 5/2022 | GreyOrange | Debt Financing | - |
| 5/2022 | GreyOrange | Venture Round | 0 |
| 3/2022 | AiFi | Series B | 0 |
| 11/2021 | Ankyra | Series B | 0 |
| 11/2021 | Helion Energy | Series E | 0 |
| 9/2021 | BlackSky Global | Post-IPO Equity | 0 |
| 6/2021 | Generation Home | Series A | 0 |
| 4/2021 | Paxos | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
